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Background: Diabetes mellitus is a heterogeneous metabolic disorders characterized by abnormally high levels of
blood glucose The main objective of the present work is to study the effect of Alpinia calcarata on glucose uptake
in streptozotocin (STZ) induced diabetic rats.
Methods: The diabetes was induced by single dose of STZ (45 mg/kg) in citrate buffer, while the normal control
group was given the vehicle (citrate buffer) only. After induction of diabetes, the diabetic animals were treated with
ethanolic extract of Alpinia calcarata (200 mg/kg) and glibenclamide (2 mg/kg) for 30 days. Blood glucose
estimation was performed every week of the study. At the end of study period, animals were sacrificed for
biochemical studies.
Results: Streptozotocin induced diabetic rats shows the altered levels of various biochemical profiles. Those levels
were brought back to near normal upon treatment with ethanolic extract of Alpinia calcarata and standard drug
glibanclamide. No significant changes were observed on treatment with plant extract alone group indicated that
there are no toxic substances present in Alpinia calcarata. The antidiabetic activity of plant extract was also further
confirmed by histopathological studies. The ethanolic extract of Alpinia calcarata shows significant inhibition of
alpha glucosidase activity and also enhancing the glucose uptake in rat hemidiaphragm.
Conclusions: In conclusion, the ethanolic extract of Alpinia calcarata ameliorates the condition associated
with diabetes.
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Diabetes mellitus is a heterogeneous metabolic disorders
characterized by abnormally high levels of blood glucose.
Diabetes mellitus has been recognized as a growing
world-wide epidemic by many health’s advocacy groups
including the World Health Organization (WHO). It is a
major public health problem affecting 285 million or 6.4%
of the world populations for the year 2010, reported by
International Diabetes Federation 2009. By 2030, this
number is estimated to rise to 435 million. Despite consid-
erable progress in the management of diabetes mellitus
using synthetic drugs, the search for improved and safe
natural anti-diabetic agents with minimal side effects is
ongoing [1].* Correspondence: dr.devaki.bc@gmail.com
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unless otherwise stated.The current treatment for control of diabetes mellitus
includes diet, exercise, oral anti diabetic drugs and insulin
therapy. However, insulin and other oral hypoglycemic
drugs have characteristic profile of adverse effects. This
has initiated the identification of novel drugs which might
act in mechanistically distinct way compared to existing
drug targets [2]. Hence, research is focused on medicinal
plants which are used in the practices and development of
newer drug leads from phytoconstituents with more po-
tential and effective agents with lesser side effects than the
existing hypoglycemic agents [3]. Many medicinal plants
are currently used in India for the treatment of diabetes
and scientifically its efficacy has been proved earlier [4].
Alpinia calcarata is one such medicinal plant which
belonging to the family Zingiberaceae. It is cultivated in
tropical countries including India, Sri Lanka and Malaysia.
The plants are widely used to relieving stomachache, treat-
ing colds, invigorating the circulatory system and reducingal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Levels of blood glucose at various stages of
study
Grouping/days 0th Day (a) 15th Day (b) 30th Day (c)
Control 110.46 ± 0.403CNS 112.46 ± 0.403CNS 111.5 ± 0.357CNS
Diabetic
control
298.33 ± 0.314** 398.66 ± 0.372** 501.7 ± 0.322**
Diabetic +
Glibenclamide








109 ± 0.403NS 110.46 ± 0.314NS 110.5 ± 0.361NS
Values are expressed as Mean ± S.D.
Values are taken as a mean of five individuals’ experiment.
a = 0th day compared with 15th day.
b = 15th day compared with 30th day.
c = 0th day compared with 30th day.
NS – Non Significant **-p < 0.05.
Figure 1 Changes in body weight in experimental rats.
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are shown to possess antibacterial, antifungal, anthelmintic,
antinociceptive, antioxidant, aphrodisiac and gastroprotec-
tive activities. The rhizomes of Alpinia calcarata is consid-
ered as aphrodisiac and used in the treatment of arthritis,
bronchitis, cough, respiratory ailments, asthma and dia-
betes [5]. The present study was conducted to evaluate the
effect of Alpinia calcarata on glucose uptake in streptozo-
tocin (STZ) induced diabetic rats.
Materials and methods
Collection of plant material
The rhizome of Alpinia calcarata were procured from
local place, identified and authentified by Dr. G.V.S.
Murthy, Botanical Survey of India, TamilNadu Agricul-
tural University (TNAU), Coimbatore (Voucher no: BSI/
SRC/5/23/09-10/Tech-982).
Preparation of solvent extraction
About 50 g of powdered plant material was mixed with
250ml of ethanol in a 500 ml conical flask and was placed
in a shaker for 16 hours. The solution was then extracted
using a separating funnel and was concentrated by solvent
evaporation using rotary evaporator. The sample material
was stored in an air tight container at 4°C and used for
further experimental analysis.
Experimental animals
Adult albino rats weighing about 150–200 g were ob-
tained from the animal house of Karpagam University,
Coimbatore and were used for the study. Rats were
housed in polycarbonate cages in a room with a 12-hour
day-night cycle, at constant temperature of 22°C and hu-
midity of 45-64%. During the experimental study, the
rats were fed on pellets (Gulmohur rat feed, Lipton
India, Bangalore) with free access to tap water. The rats
received humane care according to the criteria outlined
in Principles of Laboratory animal care, 1985.
All the experiments were carried out according to the
guidelines recommended by the Committee for the
Purpose of Control and Supervision of Experiments on
Animals (CPCSEA) and approved by Institutional Animal
Ethics Committee (IAEC), Government of India for the
use of rats as an in vivo and in vitro animal model for dia-
betic studies [6].
Experimental pattern
The animals were divided into five groups of six animals
each. Group 1 served as control animals given normal
pelleted diet and 1.0 ml citrate buffer as vehicle, group 2
rats were induced with single intraperitoneal injection of
freshly prepared streptozotocin (45 mg/kg body weight)
in 0.1 M citrate buffer (pH 4.5) in a volume of 1 ml/kg
body weight, group 3 rats were induced with diabetes andtreatment with standard drug glibenclamide (2 mg/kg
body weight) through oral intragastric tube for 30 days,
group 4 animals were induced with diabetes and treatment
with ethanolic extract of Alpinia calcarata (200 mg/kg
body weight) orally for 30 days and group 5 control rats
were treated with Alpinia calcarata only for 30 days at a
concentration of 200 mg/kg body weight.
Blood glucose levels were measured in normal and ex-
perimental rats at initial, 15th and 30th days of treatment
using electronic glucometer and the experiment was ter-
minated in overnight fasted rats at the end of 30 days.
Sacrification of animals
After experimental period, rats were sacrificed by cervical
dislocation after giving mild anesthesia using chloroform.
Blood was collected and the serum was separated by cen-
trifugation at 20000 rpm for 30 minutes. Liver and Kidney
were immediately dissected out, washed and stored in
0.9% ice cold saline for various biochemical evaluations
and tissues stored in 1% formalin were used for histo-
pathological studies. Diaphragm was used to analyze the
Table 2 Changes in levels of lipid and lipoprotein profiles in serum of experimental animals
Groups Cholesterol Triglycerides HDL LDL VLDL
(mg/dl) (mg/dl) (mg/dl) (mg/dl) (mg/dl)
Control 122.7 ± 0.32a 67.93 ± 0.36a 24.5 ± 0.31a 84.7 ± 0.32a 13.5 ± 0.31a
Diabetic control 204.4 ± 0.35b 221.9 ± 0.31b 13.4 ± 0.31b 146.5 ± 0.31b 44.5 ± 0.35b
Diabetic + Glibenclamide 112.9 ± 0.36c 71 ± 0.35c 23.16 ± 0.40c 75.5 ± 0.36a 14.23 ± 0.40ac
Diabetic + Alpinia calcarata 124.23 ± 0.31ad 89.43 ± 0.31d 30.13 ± 0.36 d 72.23 ± 0.40d 21.73 ± 0.36d
Alpinia calcarata alone 106.3 ± 0.26e 73.46 ± 0.36e 31.33 ± 0.31e 70.6 ± 0.40e 14.4 ± 0.32e
Values are expressed as Mean ± S.D. Values are taken as a mean of five individuals experiments.
Values not sharing a common superscript letter differ significantly (DMRT).
a Control group.
b Comparison between control and diabetic groups.
c Comparison between diabetic and standard drug glibenclamide treated groups.
d Comparison between diabetic and Alpinia calcarata treated groups.
e Comparison between control and Alpinia calcarata alone treated groups.
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termined inhibition of α-glycosidase activity.
Estimation of biochemical profiles
The serum was used for the analysis of glucose [7], chol-
esterol, triglycerides, HDL cholesterol was estimated by
one step method using diagnostic reagent kit manufac-
tured by Span diagnostics Ltd, VLDL was calculated by
the formulae: VLDL (mg/dl) = Triglycerides/5, LDL was
calculated by the formulae: LDL (mg/dl) = cholesterol –
HDL -VLDL, urea was estimated by DAM method using
diagnostic reagent kit manufactured by Span diagnostics
Ltd, creatinine was estimated by alkaline picrate method
using a reagent kit intended for in vitro quantitative de-
termination manufactured by Beacon diagnostics Pvt
Ltd, AST, ALT and ALP was estimated by method using
diagnostic reagent kit manufactured by Span diagnostics
Ltd.
Tissue homogenates was used to analyze the enzymatic
and non-enzymatic antioxidant and the parametersTable 3 Levels of hepatic marker enzymes in serum of
experimental animals
Groups SGOT (IU/L) SGPT (IU/L) ALP (IU/L)
Control 122.03 ± 0.314a 83.1 ± 0.322a 259.9 ± 0.314a
Diabetic
control
272.93 ± 0.361b 191.8 ± 0.372b 381.8 ± 0.422b
Diabetic +
Glibenclamide
200.9 ± 0.409c 80.96 ± 0.314c 295 ± 0.357c
Diabetic +
Alpinia calcarata
230.1 ± 0.322d 79.36 ± 0.361d 241.9 ± 0.361d
Alpinia calcarata
alone
120.03 ± 0.492ae 83.5 ± 0.389a 254.9 ± 0.409e
Values are expressed as Mean ± S.D. Values are taken as a mean of five
individuals’ experiments.
Values not sharing a common superscript letter differ significantly (DMRT).
a Control group.
b Comparison between control and diabetic groups.
c Comparison between diabetic and standard drug glibenclamide treated groups.
d Comparison between diabetic and Alpinia calcarata treated groups.
e Comparison between control and Alpinia calcarata alone treated groups.analyzed were Protein was estimated by Lowry’s et al., [8],
superoxide dismutase were determined according to the
method of Misra and Fridovich [9], catalase by Sinha [10],
glutathione peroxidase by Rotruck et al., [11], glutathione-
s- transferase by Habig et al., [12], glutathione by Moron
et al., [13], vitamin c by Omaye et al., [14], basal lipid
peroxidation by Hogberg et al., [15], ascorbate induced
lipid peroxidation was determined by Devasagayam and
Tarachand [16], peroxide induced lipid peroxidation was
estimated according to the method given by Devasagayam
and Tarachand [17].
Estimation of glucose uptake by isolated rat hemidiaph-
ragm was carried out by the method of Chattopadhyay
et al., [18] and inhibition assay for the α-glucosidase activ-
ity was done by the method of Dahlqvist [19].
Statistical analysis
All the data were expressed as Mean ± S.D. Statistical
significance was evaluated by one way analysis of vari-
ance (ANOVA) using SPSS version 7.5 (SPSS, Cary,
USA) and the individual comparisons were obtained by
the Duncan’s Multiple Range Test (DMRT). A value of
p < 0.05 was considered to indicate a significant differ-
ence between graphs.Table 4 Levels of renal markers in serum of experimental
animals
Groups Urea (mg/dl) Creatinine (mg/dl)
Control 19.3 ± 0.357a 0.75 ± 0.040a
Diabetic control 42.5 ± 0.357b 2.53 ± 0.049b
Diabetic + Glibenclamide 22.53 ± 0.361c 0.74 ± 0.053a
Diabetic + Alpinia calcarata 22.53 ± 0.361c 1.66 ±0.372c
Alpinia calcarata alone 22.2 ± 0.389c 0.66 ± 0.322d
Values are expressed as Mean ± S.D. Values are taken as a mean of five
individuals’ experiments.
Values not sharing a common superscript letter differ significantly (DMRT).
a Control group.
b Comparison between control and diabetic groups.
c Comparison between diabetic and standard drug glibenclamide treated groups.
d Comparison between control and Alpinia calcarata alone treated groups.
Table 5 Levels of enzymatic antioxidants in liver of experimental animals
Groups Superoxide dismutase Catalase Glutathione-S-transferase Glutathione peroxidase
Control 7.46 ± 0.40 a 63.06 ± 0.361a 9.07 ± 0.054a 28.11 ± 0.040a
Diabetic control 4.2 ± 0.357b 42.01 ± 0.040b 4.82 ± 0.040b 11.43 ± 0.441b
Diabetic + Glibenclamide 6.90 ± 0.045c 60.11 ± 0.03c 8.77 ± 0.054c 23.06 ± 0.049c
Diabetic + Alpinia calcarata 6.53 ± 0.044cd 58.77 ± 0.049d 8.61 ± 0.031d 26.64 ± 0.045d
Alpinia calcarata alone 7.21 ± 0.049a 64.24 ± 0.044ae 8.97 ± 0.049ae 27.25 ± 0.036e
Values are expressed as Mean ± S.D. Values are taken as a mean of five individuals experiments.
Values not sharing a common superscript letter differ significantly (DMRT).
Units:
Superoxide dismutase- Units/mg of protein.
Catalase- (μ moles of H2O2 utilized /min/mg/protein.
Glutathione-S-transferase- μmoles of CDNB-Conjugate formed/mg of protein.
Glutathione peroxidase- μg of GSH/mg of protein.
a Control group.
b Comparison between control and diabetic groups.
c Comparison between diabetic and standard drug glibenclamide treated groups.
d Comparison between diabetic and Alpinia calcarata treated groups.
e Comparison between control and Alpinia calcarata alone treated groups.
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Diabetes mellitus patients in India are increasing day by
day probably due to change in lifestyle change in food
pattern i.e. from traditional fiber rich diet to sugary fast
food diet and also because of genetic basis. The disorder
being chronic in nature needs long term treatment to
prevent the complications arising due to persistent high
blood glucose level. Pharmacotherapy available for the
treatment of diabetes in modern healthcare system in-
cludes insulin and oral hypoglycemic drugs. However
due to economic constraints, it is not possible for major-
ity of the diabetic patients in developing countries like
India to use these drugs on regular basis [20].
Moreover the synthetic antidiabetic drugs are associated
with large number of adverse effects. Hence there is in-
crease in the trend to use traditional indigenous plants
widely available in India for the treatment of diabetes melli-
tus. The effective components of medicinal plants that have
antidiabetic property include alkaloids, oligosaccharides,Table 6 Levels of enzymatic antioxidants in kidney of experim
Groups Superoxide dismutase Catala
Control 1.5 ± 0.357a 26.76 ± 0
Diabetic control 0.86 ± 0.044b 18.76 ± 0
Diabetic + Glibenclamide 1.24 ± 0.040ac 25.16 ± 0
Diabetic + Alpinia calcarata 1.03 ± 0.037bc 19.66 ± 0
Alpinia calcarata alone 1.37 ± 0.042ac 26.37 ± 0
Values are expressed as Mean ± S.D. Values are taken as a mean of five individuals
Values not sharing a common superscript letter differ significantly (DMRT).
Units:
Superoxide dismutase- Units/mg of protein.
Catalase- (μ moles of H2O2 utilized /min/mg/protein.
Glutathione-S-transferase- μmoles of CDNB-Conjugate formed/mg of protein.
Glutathione peroxidase- μg of GSH/mg of protein.
a Control group.
b Comparison between control and diabetic groups.
c Comparison between diabetic and standard drug glibenclamide treated groups.
d Comparison between control and Alpinia calcarata alone treated groups.polysaccharides, organic acids and flavonoids etc. Strepto-
zotocin (STZ) induced diabetes has been described as a
useful experimental model to study the activity of antidia-
betic agents [21]. In the present study the activity of etha-
nolic extract of Alpinia calcarata rhizome was evaluated in
streptozotocin induced diabetic rats.
The effect of the ethanolic extract Alpinia calcarata on
body weight in the STZ induced diabetic rats are shown
in Figure 1, the results indicate that the body weight of
the untreated diabetic rats was found to be significantly
decreased when compared with the normal control group.
The ethanolic extract of Alpinia calcarata ameliorated
this weight loss in STZ induced diabetic rats and from this
it is evident that the extract possesses a significant benefi-
cial effect. In diabetes mellitus, body cells are unable to
utilize glucose as a source of energy due to which proteins
are spared as energy source. This leads to decrease in pro-
tein storage which in turn reduces body weight. In the
present study streptozotocin diabetic rats show decreaseental animals
se Glutathione-S-transferase Glutathione peroxidase
.546a 7.03 ± 0.031a 31.12 ± 0.040a
.045b 3.46 ± 0.040b 14.17 ± 0.049b
.049c 6.73 ± 0.361ac 24.1 ± 0.044c
.044d 6.52 ± 0.045c 22.83 ± 0.035d
.040a 6.96 ± 0.040 a 30.12 ± 0.036a
experiments.





(μg/mg protein) (μg/mg protein)
Control 47.47 ± 0.049a 1.46 ± 0.040a
Diabetic control 28.95 ± 0.040b 0.72 ± 0.044b
Diabetic + Glibenclamide 43.53 ± 0.045c 1.37 ± 0.049cd
Diabetic + Alpinia calcarata 43.22 ± 0.033d 1.36 ± 0.045d
Alpinia calcarata alone 46.9 ± 0.035a,e 1.42 ± 0.035a,d
Values are expressed as Mean ± S.D. Values are taken as a mean of five
individuals experiments.
Values not sharing a common superscript letter differ significantly (DMRT).
a Control group.
b Comparison between control and diabetic groups.
c Comparison between diabetic and standard drug glibenclamide treated groups.
d Comparison between diabetic and Alpinia calcarata treated groups.
e Comparison between control and Alpinia calcarata alone treated groups.





(μg/mg protein) (μg/mg protein)
Control 45.76 ± 0.049a 1.20 ± 0.049a
Diabetic control 20.9 ± 0.357b 0.44 ± 0.040b
Diabetic + Glibenclamide 38.41 ± 0.040c 1.11 ± 0.044a
Diabetic + Alpinia calcarata 33.33 ± 0.314d 1.04 ± 0.035a
Alpinia calcarata alone 45.64 ± 0.045a 1.14 ± 0.045a
Values are expressed as Mean ± S.D. Values are taken as a mean of five
individual experiments.
Values not sharing a common superscript letter differ significantly (DMRT).
a Control group.
b Comparison between control and diabetic groups.
c Comparison between diabetic and standard drug glibenclamide treated groups.
d Comparison between control and Alpinia calcarata alone treated groups.
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Oral treatment with aqueous extract of Alpinia calcarata
significantly improved the body weight loss in diabetic rats
as compared to diabetic control indicating possible role of
the extract in restoration of protein metabolism. Hence,
the weight gain after administration of the extract in se-
verely diabetic rats is simply due to the ability of the ex-
tract to reduce diabetes [23].
Levels of blood glucose in experimental rats were
shown in Table 1. Streptozotocin (STZ) diabetic rats ex-
hibited significant increase in blood glucose level.
Upon treatment with ethanolic extract of Alpinia
calcarata the blood glucose level was reduced throughout
the experimental period in duration dependent manner in-
dicating its antihyperglycemic activity. However blood glu-
cose levels were not altered in normoglycemic rats further
strengthening the antidiabetogenic potential of the extract.
Metabolic disturbances of carbohydrates, lipids and
proteins during diabetes mellitus cause insulin deficiency
stimulating lipolysis in adipose tissues, therefore this
leads to fatty liver, hypercholesterolemia and hypertri-
glyceridemia. Furthermore increased triglycerides result
in increase in free fatty acid level and its oxidation dis-
turbs metabolism as well as utilization of glucose and
also impairs insulin action leading to development of
hyperglycemia [24]. The levels of lipid and lipoprotein
profiles such as cholesterol, triglycerides, HDL, VLDL and
LDL cholesterol in serum of experimental animals were
depicted in Table 2. The levels of cholesterol, triglyceride,
VLDL and LDL in serum were increased (p < 0.05) signifi-
cantly whereas the level of lipoprotein lipase and HDL
was decreased significantly (p < 0.05) in STZ induced ani-
mals when compared to control animals. Upon adminis-
tration of Alpinia calcarata extract and glibenclamide the
levels were significantly reverted back to the near normal
levels when compared to normal animals. No significant
changes were observed in plant extract alone treated ani-
mals when compared to control animals.
The present study showed increase in serum triglycer-
ides, total cholesterol and LDL cholesterol with decrease
in HDL cholesterol supporting the findings of the other
researchers [23]. Potential of the extract to decrease
cholesterol and triglyceride levels could be helpful in im-
proving lipid metabolism in diabetics which in turn will
help to prevent diabetic complications. LDL- cholesterol
being involved in the transport of cholesterol from liver
to peripheral tissues is the key factor in atherogenesis. Po-
tential of the extract to reduce LDL-cholesterol thereby
indicates its possible involvement in the prevention of dia-
betes mellitus induced cardiovascular complications [25].
The activities of AST, ALT and ALP in serum of ex-
perimental animals were shown in Table 3. The activities
of these enzymes were found to be significantly in-
creased (p < 0.05) in diabetes induced animals than incontrol animals. On treatment with plant extract, the
levels were significantly decreased in a dose dependent
manner showing a favourable change in groups treated
with 200 mg/kg. Treatment with ethanolic extract alone
did not show any significant difference when compared
to normal control group.
The measurement of the activities of marker or diag-
nostic enzymes in serum plays a significant and well-
known role in diagnosis, disease investigation and in the
assessment of drug or plant extract for safety or toxicity
risk. The enzymes considered in this study are useful
marker enzymes of liver cytolysis and damage to the
plasma membrane of the liver cells. In the present study
shows an increased in the level of serum marker en-
zymes in STZ induced diabetes indicating that STZ ad-
ministration produced hepatic damage [26].
The levels of urea and creatinine were shown in
Table 4. The levels of urea and creatinine were significantly
increased in group II diabetic induced animals. These










Control 11.05 ± 0.04a 13.76 ± 0.04a 9.93 ± 0.36a
Diabetic control 25.9 ± 0.32b 32.34 ± 0.03b 23.34 ± 0.04b
Diabetic + Glibenclamide 14.76 ± 0.03c 18.3 ± 0.04c 13.33 ± 0.04c
Diabetic + Alpinia
calcarata
15.9 ± 0.04d 19.88 ± 0.04d 14.45 ± 0.04d
Alpinia calcarata alone 11.4 ± 0.04a 14.22 ± 0.05e 10.33 ± 0.03e
Values are expressed as Mean ± S.D. Values are taken as a mean of five
individual experiments.
Values not sharing a common superscript letter differ significantly (DMRT).
Units:
Lipid peroxidation- nmoles of MDA formed/g tissue.
a Control group.
b Comparison between control and diabetic groups.
c Comparison between diabetic and standard drug glibenclamide treated groups.
d Comparison between diabetic and Alpinia calcarata treated groups.
e Comparison between control and Alpinia calcarata alone treated groups.
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treated animals. Whereas, the group V plant extract
alone rats the above levels were similar to the control
groups. Kidney maintains optimum chemical compos-
ition of body fluid by acidification of urine and removal
of metabolic wastes such as urea, uric acid, creatinine
and ions. During renal diseases, the concentration of these
metabolites increases in blood [27]. In the present study it
was observed that, administration of plant extract at 200
mg/kg doses reduced elevated levels of urea and creatinine,
which was comparable to the effect observed with gliben-
clamide. This indicates the prevention of kidney dam-
age, which may be possible in diabetic animals [28].
Tables 5 and 6 shows the effect of ethanolic extract of
Alpinia calcarata. The results showed that the activity
of catalase, superoxide dismutase, glutathione peroxidase
and glutathione-S-transferase decreased significantly in
STZ induced diabetic group compared to normal control
group. Ethanolic extract of Alpinia calcarata treatedTable 10 Effect of Alpinia calcarata on glucose uptake in isola
Particulars Control Diabeti
Tyrode solution with glucose (2 g%) 6.02 ± 0.10a 5.0 ±
Tyrode solution with glucose (2 g%) + insulin
(0.25 IUmL-1 )
10.02 ± 0.12a 11.04
Tyrode solution with glucose (2 g%) + Rhizome
extract (200 mg L-1)
8.01 ± 0.06a 9.02 ±
Tyrode solution with glucose (2 g%) + insulin
(0.25 IUmL 1) + Rhizome extract (200 mg mL-1)
12.01 ± 0.10a 14.02
Values are expressed as Mean ± S.D. Values are taken as a mean of five individual e
Values not sharing a common superscript letter differ significantly (DMRT).
a Control group.
b Comparison between control and diabetic groups.
c Comparison between diabetic and standard drug glibenclamide treated groups.
d Comparison between diabetic and Alpinia calcarata treated groups.
e Comparison between control and Alpinia calcarata alone treated groups.diabetic rats is significantly increased the antioxidant en-
zyme activities and reversed them to their near normal
levels. The same phenomenon was seen in the results of
glibenclamide treated groups. Normal rats treated with
ethanolic extract of Alpinia calcarata showed the same
effect as that of control rats and there was no significant
change.
An imbalance between the production and scavenging
of free radicals can result in increased oxidative stress.
Increased free radical generation and oxidative stress are
hypothesized to play an important role in the pathogen-
esis of diabetes and its later complications. Diabetic state
is shown to be associated with depletion of antioxidants
[29]. Administration of Alpinia calcarata showed a pro-
tective effect against free radical damage.
In liver and kidney the concentration of vitamin C
and glutathione was decreased significantly in un-
treated diabetic rats, when compared to the normal
groups. On treatment with Alpinia calcarata, signifi-
cant increase in the levels of non-enzymatic antioxi-
dants when compared with untreated diabetic rats
were observed. There was no change in the level of
the above parameters in the rats which were given
the plant extract alone and is almost similar to con-
trol group (Tables 7 and 8). Antioxidants exist in
interconvertable (reduced and oxidized) forms. The
decreased level of ascorbic acid in diabetic rats may
be due to either increased utilization as an antioxi-
dant defense against increased ROS or to a decrease
in glutathione level since glutathione is required for
the recycling of ascorbic acid [30].
Lipid peroxidation is a free radical mediated process
leading to oxidative deterioration of polyunsaturated
lipids. Under normal physiological conditions, low con-
centrations of lipid peroxides are found in plasma and
tissues. Oxygen derived free radicals generated in excess
in response to various stimuli could be cytotoxic to sev-
eral tissues. Most of the tissue damage is considered toted rat hemidiaphragm- in vitro assay






0.08b 7.0 ± 0.12c 9.04 ± 0.10d 8.0 ± 0.10e
± 0.09b 11.99 ± 0.10c 13.0 ± 0.12d 9.01 ± 0.10e
0.08b 6.99 ± 0.10c 10.02 ± 0.10d 12.03 ± 0.11e
± 0.10b 14.02 ± 0.11b 13.00 ± 0.09c 11.0 ± 0.12d
xperiments.
Table 11 In vitro alpha glucosidase inhibition using
Alpinia calcarata
Concentration % inhibition of α-glucosidase activity
(μg/ml) Ethanolic extract of Alpinia calcarata Acarbose
50 6.2 ± 0.70 19.22 ± 0.03
100 19.2 ± 0.86 35.43 ± 0.01
200 29.2 ± 1.89 50.03 ± 0.02
400 45.7 ± 1.80 67.58 ± 0.03
500 59.4 ± 1.78 88.12 ± 0.01
IC50 (μg/ml) 435 ± 3.57 200 ± 4.03
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branes through peroxidation of polyunsaturated fatty
acids. The increase in oxygen free radicals in diabetes
could be primarily due to increase in blood glucose levels,
which upon auto-oxidation generate free radicals [31].Figure 2 Histopathological examination of liver (100x magnification).The effect of the ethanolic extract of Alpinia calcarata
on the liver and kidney lipid peroxidation is given in
Table 9. The elevated levels of basal lipid peroxidation,
ascorbate induced lipid peroxidation and peroxide in-
duced lipid peroxidation in streptozotocin induced dia-
betic rats was reduced significantly to near normal levels
upon treatment with Alpinia calcarata extract and the
standard drug glibenclamide. The plant extract alone
treated rats did not show any significant change. The
increased susceptibility of the tissues of the diabetic ani-
mals may be due to the activation of the lipid peroxida-
tion system. The possible source of oxidative stress in
diabetes includes shifts in redox balance resulting from
altered carbohydrate and lipid metabolism, increased
generation of reactive oxygen species [32].
Glucose uptake increased significantly with insulin
alone treated rats and rhizome of Alpinia calcarata
alone treated rats, but the uptake is more in insulin
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http://www.jdmdonline.com/content/13/1/33treated group than the rhizome treated group. Treat-
ment of rats with both insulin and Alpinia calcarata in-
crease the glucose uptake very significantly. In Alpinia
calcarata alone treated group increased the glucose up-
take in rat hemidiaphragm which was higher than that
of insulin treated diaphragms (Table 10). The enhanced
glucose utilization of hemidiaphragm in presence of
rhizome extract revealed that the glucose uptake is
similar to that of insulin. These findings suggest that
the ethanolic extract of Alpinia calcarata may have
direct insulin like activity which enhances the periph-
eral utilization of glucose and have extra pancreatic
effect [26].Figure 3 Histopathological examination of kidney (100x magnificatioIn vitro α-glucosidase inhibition of the ethanolic
extract of Alpinia calcarata treated rats showed a sig-
nificant inhibitory action of alpha glucosidase enzyme
(Table 11). The results revealed that plant extract
showed 6.2% of inhibition at 50 μg/ml and 59.4% of
inhibition at 500 μg/ml. There was a proportionate in-
crease in the percentage of α- glucosidase inhibition in a
concentration dependent manner. Acarbose was used as
a reference standard for the evaluation of α- glucosidase
inhibitory action.
Alpha glucosidase are the enzymes involved in the
metabolism of carbohydrates. Alpha amylase degrades
complex dietary carbohydrates to oligosaccharides andn).
Rajasekar et al. Journal of Diabetes & Metabolic Disorders 2014, 13:33 Page 9 of 11
http://www.jdmdonline.com/content/13/1/33disaccharides, which are ultimately converted into
monosaccharide by alpha glucosidase. Liberated glucose is
then absorbed by the gut and results in postprandial hyper-
glycemia. Inhibition of alpha glucosidase limits postpran-
dial glucose levels by delaying the process of carbohydrate
hydrolysis and absorption. The plant based alpha glucosi-
dase inhibitor offers a prospective therapeutic approach for
the management of post-prandial hyperglycemia [33]. In
the present study, Alpinia calcarata exhibited appreciable
alpha glucosidase inhibitory effects when compared with
standard drug acarbose.
Histopathological study
Histopathology of the liver of control animals showed nor-
mal hepatic structure. In diabetic control rats, liver sectionsFigure 4 Histopathological examination of pancreas (100x magnificatshowed sinusoidal dilation, feathery degeneration and ne-
crosis. In diabetic animals treated with glibenclamide, liver
sections maintained lobular architecture, mild sinusoidal
dilation, and congestion. Liver of diabetic animals treated
with ethanolic extract of Alpinia calcarata showed mild
periportal aggregation of lymphocytes. The sinusoids ap-
peared mildly congested and the central veins are appeared
normal. There was no hepatocellular necrosis and no evi-
dence of steatosis. In the case of liver sections of rats
treated with Alpinia calcarata extract alone, the control
veins, portal triads, zone 1, 2 and 3 hepatocytes and the si-
nusoidal spaces appear normal (Figure 2).
Histopathology of the kidney (Figure 3) in control
animals, showed normal histology. In diabetic control,
kidney section showed severe tubular epithelial atrophy.ion).
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sections maintained mild tubular epithelial atrophy. Kid-
ney of diabetic animal treated with ethanolic extract of
Alpinia calcarata showed mild tubular atrophy. The
normal animal treated with plant extract of Alpinia cal-
carata alone showed normal histological structure.
Histopathology of the pancreas (Figure 4) of control ani-
mals showed normal histology. In diabetic control rats,
pancreas sections showed severe congestion of pancreatic
parenchyma and hyperplasia of cells. In the case of dia-
betic animals treated with glibenclamide, pancreas sec-
tions maintained mild hyperplasia of islet cells. Pancreas
of diabetic animal treated with ethanolic extract of Alpinia
calcarata showed normal exocrine pancreas. The islet cells
appeared normal and there was no inflammation or de-
position of amyloid. A peripancreatic lymph node seen in
histopathology which was also appeared normal. In case
of the normal animals treated with ethanolic extract of
Alpinia calcarata, studied showed exocrine pancreatic tis-
sue, adipose tissue and a few islands of endocrine tissue.
Conclusion
Thus the present study showed that the rhizome of Alpinia
calcarata possesses antidiabetic and antihyperlipidemic ef-
fects in streptozotocin induced diabetic rats. It can be con-
cluded from the data that ethanolic extract rhizome extract
supplementation is beneficial in controlling the blood glu-
cose level, improves the lipid metabolism and prevents dia-
betic complications from lipid peroxidation and antioxidant
systems in experimental diabetic rats. This could be useful
for prevention or early treatment of diabetic disorders.
Competing interest
We, the authors declare that there is no competing interest.
Authors’ contribution
‘RR’ and ‘KM’ designed the study. ‘RR’ develop the protocol and wrote the
first and second drafts of the manuscript. ‘RR’ and KM’ performed the
experimental works. ‘NR’ ‘GD’ and ‘DK’ involved in the collection of literature,
interpret the results and performed the statistical analysis. All authors read
and approved the final manuscript.
Acknowledgement
We, the authors are thankful to our Chancellor, Advisor, Vice Chancellor and
Registrar of Karpagam University for providing facilities and encouragement.
Author details
1Department of Biochemistry, Karpagam University, Coimbatore 641 021,
Tamilnadu, India. 2PG & Research Department of Biotechnology, Kongunadu
Arts and Science College, Coimbatore 641 029, Tamilnadu, India.
3Department of Biochemistry, College of Medical Lab Technology, Acharya
Institute of Health Science, Bangalore, India.
Received: 4 September 2013 Accepted: 25 January 2014
Published: 6 February 2014
References
1. June CC, Wen LH, Sani HA, Latip J, Gansau JA, Chin LP, Embi N, Sidek HM:
Hypoglycemic effects of gynura procumbens fractions on streptozotocin-
induced diabetic rats involved phosphorylation of GSK3β (Ser-9) in liver.
Sains Malays 2012, 41:969–975.2. Palsamy P, Subramanian S: Resveratrol, a natural phytoalexin, normalizes
hyperglycemia in streptozotocin-nicotinamide induced experimental
diabetic rats. Biomed Pharmacother 2008, 62:598–605.
3. Chandramohan G, Ignacimuthu S, Pugalendi KV: A novel compound from
Cascaria esculenta (Roxb) root and its effect on carbohydrate metabolism
in streptozotocin diabetic rats. European J Pharmacol 2008, 590:437–443.
4. Are PC, Adidala RRR, Puchchakayala G: Hypoglycemic and antidiabetic
activity of glochidion velutinum on streptozotocin-nicotinamide induced
type 2 diabetic rats. Eur J Biol Sci 2011, 3:126–130.
5. Arambewela LSR, Arawwawala LDAM, Ratnasooriya WD: Hypoglycemic and
antihyperglycemic activities of the aqueous and the ethanolic extracts of
Alpinia calcarata rhizomes in rats. Pharmacog Mag 2009, 5:412–418.
6. Ezekwesili CN, Ogbunugafor HA, Ezesili-Ofili JO: Anti-diabetic activity of
aqueous extracts of Vitex doniana leaves and Cinchona calisaya bark in
alloxan–induced diabetic rats. Int J Trop Disease 2012, 2(4):290–300.
7. Sasaki T, Matsy S, Sonae A: Effect of acetic acid concentration on colour
reaction in O-Toluidine boric acid method for blood glucose estimation.
Rinsho Kagaku 1972, 1:346–353.
8. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with
Folin phenol reagent. J Biol Chem 1952, 193:265–275.
9. Misra HP, Fridovich A: Assay of superoxide dismutase. J Biol Chem 1972,
247:3170–3175.
10. Sinha AK: Colorimetric assay of catalase. Anal Biochem 1972, 47:389–394.
11. Rotruck JT, Pope AL, Ganther HE, Swanson AB, Hafeman DG, Hoekstra WG:
Selenium: biochemical role as a component of glutathione peroxidase.
Science 1973, 179:588–590.
12. Habig WH, Pabst MJ, Jakoby WB: Glutathione S-Tranferase. The first enzyme
step in mercapturic acid formation. J Biol Chem 1981, 249:7130–7139.
13. Moron MS, Depierre JW, Mannervik B: Levels of glutathione, glutathione
reductase and glutathione S-transferase activities in rat lung and liver.
Biochem Biophys 1979, 582:67–78.
14. Omaye ST, Turnbull JD, Sauberlich HE: Selected methods for the
determination of ascorbic acid in animal cell, tissue and fluids. In
Methods In Enzymology. Edited by McCormick DB, Wright LD. New York:
Academic; 1973:1–11.
15. Hogberg J, Larson RE, Kristoferson A, Orrhenices IS: NADPH dependent
reductase solublised from microsome by peroxidation and its activity.
Biochem Biophys Res Commun 1974, 56:836–842.
16. Devasagayam TPA, Tarachan U: Decreased lipid peroxidation in the rat
kidney during gestation. Bichem Biophys Res Commun 1987, 56:836–842.
17. Chattopadhyay RR, Sarkar SK, Ganguli S, Banerjee RN, Base TK: Effect of
extract of leaves of Vinca rosea Linn on glucose utilization and glycogen
deposition by isolated rat hemidiaphragm. Indian J Physiol Pharmacol
1992, 36:137–138.
18. Dahlqvist A: Method for assay of intestinal disaccharides. Anal Biochem
1964, 7:18–25.
19. Tiwari AK, Madhusudana RJ: Diabetes mellitus and multiple therapeutic
approaches of phytochemicals: Present status and future prospectus.
Curr Sci 2002, 83:30–38.
20. Vuyyuru AB, Govindarao M, Ravi Chandra Sekhara Reddy D, Harish B,
Vishwanath J, Amarnath Reddy G: Antidiabetic activity of hydroalcoholic
extract of Ananas comosus L. leaves in streptozotocin induced diabetic
rats. Int J Pharm 2012, 2:142–147.
21. Guyton AC, Hall JE: Textbook of Medical Physiology. 9th editionPhiladelphia:
WB Saunders; 1996.
22. Ravi K, Ramachandran B, Subramanian S: Protective effect of Eugenia
jambolana seed kernal on tissue antioxidants in streptozotocin induced
diabetic rats. Biol Pharm Bull 2004, 27:1212–1217.
23. Davis SN, Granner DK: Insulin, Oral hypoglycemic agents and the
pharmacology of the endocrine pancreas. In Goodman and Gillman’s the
Pharmacological Basis of Therapeutics. 10th edition. Edited by Hardman JG,
Limberd LE. USA: McGrew Hill; 2001:1679–1714.
24. Bandawane D, Juvekar A, Juvekar M: Antidiabetic and antihyperlipidemic
effect of Alstonia scholaris Linn bark in streptozotocin induced diabetic
rats. Indian J Pharm Edu Res 2011, 45:114–120.
25. Sivajyothi V, Dey A, Jaykar B, Rajkapoor B: Antihyperglycemic,
antihyperlipidemic and antioxidant effect of Phyllanthus rheedii on
streptozotocin induced diabetic rats. Iran J Pharm Res 2008, 7:53–59.
26. Radhika R, Ragavan B, Sharad Pawar D, Sudarsanam D: Action of marker
enzymes of Rheum emodi in alloxan induced diabetic rats. Asian J Exp
Biol Sci 2012, 3:420–423.
Rajasekar et al. Journal of Diabetes & Metabolic Disorders 2014, 13:33 Page 11 of 11
http://www.jdmdonline.com/content/13/1/3327. Jaspreet V, Sivakami S, Shahani S, Suthar AC, Banaralikar MM, Biyani MK:
Antihyperglycemic effect of three extract from Monordica charantia.
J Ethnopharmacol 2000, 88:107–111.
28. Ashish B, Swapnil G: Hypoglycemic Effect of polyherbal formulation in
alloxan induced diabetic rats. Pharmacologyonline 2011, 3:764–773.
29. Jeyashanthi N, Ashok V: Antioxidative effect of Cassia auriculata on
streptozotocin induced diabetic rats. Indian J Clin Biochem 2010,
25:429–434.
30. Punitha ISR, Rajendran K, Shirwaikar A, Shirwaikar A: Alcoholic stem extract
of Coscinium fenestratum regulates carbohydrate metabolism and
improves antioxidant status in streptozotocinnicotinamide induced
diabetic rats. eCAM 2005, 2:375–381.
31. Malini P, Kanchana G, Rajadurai M: Antiperoxidative and antioxidant effect
of ellagic acid on normal and streptozotocin induced diabetes in albino
wistar rats. Res J Pharm Biol Chem Sci 2011, 2:33.
32. Laight DW, Carrier MJ, Anggard EE: Antioxidants, diabetes and endothelial
dysfunction. Cardiovasc Res 2000, 47:457–464.
33. Sunil C, Latha PG, Suja SR, Shine VJ, Shayamal, Anju GI: Effect of ethanolic
extract of Pisonia alba span leaves on blood glucose levels and
histologial changes in tissues of Alloxan induced diabetic rats. Int J Appl
Res Nat Prod 2009, 2:4–11.
doi:10.1186/2251-6581-13-33
Cite this article as: Rajasekar et al.: Effect of Alpinia calcarata on glucose
uptake in diabetic rats-an in vitro and in vivo model. Journal of Diabetes
& Metabolic Disorders 2014 13:33.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
